SUBSCRIBE
SUBSCRIBE

Abbott Laboratories

NEWS
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
M&A Bonanza Continues as Johnson & Johnson Pays $4.325 Billion for Abbott’s Eye Surgery Biz
September 16, 2016
 · 
2 min read
Abbott Managers in India Allegedly Instructed Employees to Pursue Sales at Any Cost
Job Trends
Abbott Managers in India Allegedly Instructed Employees to Pursue Sales at Any Cost
August 11, 2016
 · 
3 min read
Business
Abbott Sales Rep in India Blames Company in Suicide Note
July 25, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Abbott Tries to Bail Out of $5.8 Billion Deal as Alere Faces Bribery Probes, But it Won’t Be Easy
June 2, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Abbott Tries to Back Out of $5.8B Alere Deal, But Alere Says It’s Still On
April 29, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Abbott’s $25 Billion Bid for St. Jude Medical Raises Questions About Pending Alere Deal
April 28, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Alere Stock Falls as Abbott CEO Declines to Comment and Confirm $6 Billion Deal
April 21, 2016
 · 
2 min read
Biotech Bay
Smart Sensor That Ends Diabetes Finger Prick Tests, Abbott Reveals
April 19, 2016
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Drugmaker Abbott Snaps Up Alere for $5.8 Billion
February 1, 2016
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Business
Abbott Reports Third-Quarter 2021 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance
October 20, 2021
 · 
28 min read
BioMidwest
Abbott Commits to Reducing Malnutrition Globally with Launch of Abbott Center for Malnutrition Solutions
September 30, 2021
 · 
5 min read
FDA
Abbott Receives FDA Approval for Minimally Invasive Portico™ with FlexNav™ TAVR System to Treat Patients with Aortic Valve Disease
September 20, 2021
 · 
3 min read
Deals
Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC
September 2, 2021
 · 
2 min read
BioMidwest
Late-Breaking Data Shows Abbott’s Amplatzer™ Amulet™ Occluder Offers Superior Left Atrial Appendage Closure Compared to Watchman‡ Device for People With Atrial Fibrillation at Risk of Stroke
August 30, 2021
 · 
4 min read
FDA
Abbott’s Amplatzer™ Amulet™ Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke
August 16, 2021
 · 
3 min read
BioMidwest
Late-Breaking Data Demonstrate Abbott’s FreeStyle® Libre System Supports Health Equity for Millions of Americans Living with Diabetes
June 25, 2021
 · 
8 min read
BioMidwest
Abbott Receives CE Mark for Navitor™, the Latest-Generation Transcatheter Aortic Valve Implantation (TAVI) System to Treat Aortic Stenosis
May 17, 2021
 · 
4 min read
BioMidwest
Abbott Seeks Better Treatment Options for Patients with Both Atrial Fibrillation and Heart Failure with New Trial
May 6, 2021
 · 
5 min read
BioMidwest
Abbott Begins Shipping BinaxNOW™ COVID-19 Ag Self Test to Retailers Today
April 19, 2021
 · 
8 min read
Load More